Custom service

Peptide Lipidation

Install lipid chains on peptides beyond standard fatty-acid conjugation

Turnaround: 4–7 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: cholesterol and tocopherol conjugation; diacyl and branched-chain lipid motifs; cleavable lipid-linker designs

The service is built around cholesterol and tocopherol conjugation. Depending on the molecule we may move to diacyl and branched-chain lipid motifs or cleavable lipid-linker designs to improve stability, loading or yield, and every batch is released with lipidated peptide with lipid-ratio and solubility data.

Because Peptide Lipidation projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Membrane-anchored peptide probes

Self-assembling lipid–peptide materials

Lipidation requiring GMP-controlled manufacturing

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • Cholesterol and tocopherol conjugation as the default route, with diacyl and branched-chain lipid motifs held as a proven fallback
  • Cleavable lipid-linker designs worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Lipidated peptide with lipid-ratio and solubility data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — cholesterol and tocopherol conjugation, diacyl and branched-chain lipid motifs — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Lipidated peptide with lipid-ratio and solubility data is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
4–7 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
cholesterol and tocopherol conjugation; diacyl and branched-chain lipid motifs; cleavable lipid-linker designs
Deliverable
Lipidated peptide with lipid-ratio and solubility data
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.